Anzeige
Mehr »
Login
Dienstag, 22.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Endlich!!! Gold-Aktien explodieren! Jetzt die Chance auf riesige Gewinne nutzen – mit dieser Aktie!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
713 Leser
Artikel bewerten:
(2)

ForFarmers N.V.: ForFarmers Q3 2022 Trading Update

Lochem, 1 November 2022

ForFarmers Q3 2022 Trading Update

Highlights for third quarter of 20221:

  • Total Feed volume2: down by 7.2%; decline mainly in the swine and layer sectors
    of which compound feed: down by 9.1%
  • Gross profit: up by 8.3%
  • Underlying EBITDA: down by 17.3%; higher expenses could not be passed on fully in the supply chain

1 Results and developments of the third quarter 2022 are compared to the third quarter 2021, unless otherwise stated
2 Total Feed comprises the entire product portfolio of ForFarmers and consists of compound feed, specialties, co-products (such as residual flows from the food industry, referred to by ForFarmers as DML products), seeds and other products (such as forage).

ForFarmers CFO Roeland Tjebbes said:
"Volatile markets due to the war in Ukraine and the exceptionally long and hot summer determined results in the third quarter. We could not fully pass on the higher energy costs nor the inbound freight costs due to the low water levels in the rivers. Particularly pig farmers and layer farmers were affected by the (financial) consequences of outbreaks of animal diseases. We consequently saw our volumes in these sectors drop. In Poland, however, we again sold more feed to broiler farmers and our volumes were also up in the ruminant sector in the Netherlands and the United Kingdom. Raw material prices were somewhat lower than in the second quarter. This was a positive development for all farmers, but not yet sufficient for pig farmers. In general, they continued to produce at a loss. The increase of gross profit was not enough to cover the higher operating expenses, which included energy costs which were roughly twice as high as a year before. This consequently resulted in our consolidated underlying EBITDA being a few million lower than a year earlier. On a quarterly basis this translates into a relatively high percentage. Excluding the higher energy costs, underlying EBITDA in the third quarter of 2022 would have been roughly the same as in the third quarter of 2021.
Our markets are and will likely continue to be volatile. In such challenging markets we are well aware that we can rely on loyal customers and dedicated employees. They make the difference, and we are grateful for that. We remain committed to our customers and other stakeholders and will provide more insight into how we intend to continue to do so in the coming years on 17 November. Moreover, we hope to soon be able to provide more clarity on the planned joint venture with 2Agriculture in the United Kingdom, with which we will further strengthen our position in the poultry sector."

Read the full press release on our websiteor download the file at the bottom of this message.

This press release contains information that qualifies as inside information within the meaning of Article 7 paragraph 1 of the EU Market Abuse Regulation.


Note to the editor / For further information:
Caroline Vogelzang, Director of Investor Relations
M +31

About ForFarmers
ForFarmers N.V. is an international organisation that provides complete innovative feed solutions to the livestock farming industry. With its For the Future of Farming mission ForFarmers underpins its commitment both to the continuity of farming and to further increasing the sustainability of the agricultural sector. ForFarmers is the market leader in Europe with annual sales of around 10 million tonnes of animal feed and is active in the Netherlands, Belgium, Germany, Poland and the United Kingdom. ForFarmers has around 2,500 employees and in 2021 generated revenue of approximately €2.7 billion. ForFarmers N.V. is listed on Euronext Amsterdam.

ForFarmers N.V.
P.O. Box 91
7240 AB Lochem
The Netherlands
T: +31, www.forfarmersgroup.eu

FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements, for example relating to ForFarmers' legal obligations in terms of capital and liquidity positions in certain specified scenarios. In addition forward-looking statements may, without limitation, contain phrases such as "intends to", "expects", "takes into account", "is aimed at", 'plans to", "estimates" and/or words of a similar meaning. These statements pertain to or may affect matters in the future, such as ForFarmers' future financial results, business plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties which may lead to material differences between the actual results and performance and the expected future results or performance as implicitly or explicitly contained in the forward-looking statements. Factors that may result in, or contribute to, deviations from current expectations include, but are not limited to developments in legislation, technology, taxation, jurisprudence and regulations, share price fluctuations, legal proceedings, investigations by regulatory bodies, the competitive landscape and general economic conditions. These and other factors, risks and uncertainties that may affect any forward-looking statements or the actual results of ForFarmers are discussed in the most recently published annual report. The forward-looking statements in this press release relate solely to statements as of the date of this document and ForFarmers accepts no obligation or responsibility whatsoever to update the forward-looking statements contained in this release, regardless of whether these pertain to new information, future events or otherwise, unless ForFarmers is legally obliged to do so.

Attachment

  • 20221101_Press release _ForFarmers Q3 2022 Trading Update (https://ml-eu.globenewswire.com/Resource/Download/f495ad24-dad8-47b3-bd74-fc7c3896c65b)

© 2022 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.